Kepos Capital’s Traws Pharma TRAW Stock Holding History

Kepos Capital’s Portfolio TRAW Stock Details TRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-342	Closed	-$49K	–	326
2019 Q4	$49K	Hold	342	–	–	﹤0.01%	351
2019 Q3	$109K	Hold	342	–	–	0.01%	298
2019 Q2	$365K	Hold	342	–	–	0.04%	250
2019 Q1	$423K	Hold	342	–	–	0.03%	288
2018 Q4	$271K	Sell	342 -191	-36%	-$326K	0.02%	308
2018 Q3	$1.47M	Hold	533	–	–	0.08%	192
2018 Q2	$1.21M	Buy	+533	New	+$1.55M	0.06%	209

Other funds holding TRAW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HWA

Hillcrest Wealth Advisors Hazlet, New Jersey $279M AUM 21.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Quilter Plc London, United Kingdom $5.7B AUM 21.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kepos Capital's TRAW Position: Q1 2020 in Review

Kepos Capital sold out of Traws Pharma (TRAW) in Q1 2020, closing a stake of 342 shares — an estimated $49K sold.

Kepos Capital first reported a position in TRAW in Q2 2018 and held it in 7 quarters. The position peaked at $1.47M in Q3 2018. 21 funds tracked by Wall St. Rank hold TRAW as of Q1 2020.

Kepos Capital reported no remaining Traws Pharma position as of Q1 2020 after selling out during the quarter.
Kepos Capital sold 342 Traws Pharma shares in Q1 2020, an estimated $49K.
Kepos Capital first reported a position in Traws Pharma in Q2 2018 and held it in 7 quarters.
Kepos Capital's Traws Pharma position peaked at $1.47M in Q3 2018.
21 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2020.

Based on Kepos Capital's 13F filing for Q1 2020, filed 12 May 2020.